Investigation of ethyl cellulose microsponge gel for topical delivery of eberconazole nitrate for fungal therapy.
Bothiraja C, Gholap AD, Shaikh KS, Pawar AP.
Ther Deliv · journal article · DOI 10.4155/tde.14.43 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för eberconazole. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
15 träffarEfficacy and safety of terbinafine hydrochloride 1% cream vs eberconazole nitrate 1% cream in localised tinea corporis and tinea cruris.
Choudhary SV, Aghi T, Bisati S.
Indian Dermatol Online J · research-article; journal article · DOI 10.4103/2229-5178.131079Validated Stability-indicating High-performance Liquid Chromatographic Method for Estimation of Degradation Behaviour of Eberconazole Nitrate and Mometasone Furoate in Cream Formulation.
Sharma N, Rao SS, Vaghela B.
Indian J Pharm Sci · research-article; journal article · DOI 10.4103/0250-474x.113530Eberconazole--pharmacological and clinical review.
Moodahadu-Bangera LS, Martis J, Mittal R, Krishnankutty B, Kumar N, Bellary S, Varughese S, Rao PK.
Indian J Dermatol Venereol Leprol · review; journal article · DOI 10.4103/0378-6323.93651Eberconazole 1% cream is an effective and safe alternative for dermatophytosis treatment: multicenter, randomized, double-blind, comparative trial with miconazole 2% cream.
Repiso Montero T, López S, Rodríguez C, del Rio R, Badell A, Gratacós MR.
Int J Dermatol · clinical trial, phase iii; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1111/j.1365-4632.2006.02841.xEvaluation of disk diffusion method for determining eberconazole susceptibility of dermatophytes and influence of culture medium.
Fernández-Torres B, Inza I, Guarro J.
Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.49.5.2116-2118.2005Eberconazole cream: topical and general tolerability, sensitisation potential, and systemic availability.
Barbanoj MJ, Antonijoan R, García-Gea C, Puntes M, Gich I, Jané F.
Methods Find Exp Clin Pharmacol · clinical trial; research support, non-u.s. gov't; journal article · DOI 10.1358/mf.2005.27.4.893581In vitro activities of the new antifungal drug eberconazole and three other topical agents against 200 strains of dermatophytes.
Fernández-Torres B, Inza I, Guarro J.
J Clin Microbiol · research-article; journal article · DOI 10.1128/jcm.41.11.5209-5211.2003Eberconazole (Eberconazol, Eberconazole nitrate, WAS 2160).
Författaruppgift saknas
Drugs R D · journal article · DOI 10.2165/00126839-200203050-00011A double-blind randomized comparative trial: eberconazole 1% cream versus clotrimazole 1% cream twice daily in Candida and dermatophyte skin infections.
del Palacio A, Ortiz FJ, Pérez A, Pazos C, Garau M, Font E.
Mycoses · clinical trial, phase iii; comparative study; clinical trial; randomized controlled trial; journal article · DOI 10.1046/j.1439-0507.2001.00632.xIn vitro susceptibilities of clinical yeast isolates to the new antifungal eberconazole compared with their susceptibilities to clotrimazole and ketoconazole.
Torres-Rodríguez JM, Mendez R, López-Jodra O, Morera Y, Espasa M, Jimenez T, Lagunas C.
Antimicrob Agents Chemother · comparative study; research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.43.5.1258[Topical treatment with eberconazole of the experimental guinea pig cutaneous candidosis.].
Torres-Rodríguez JM, Madrenys-Brunet N, Montsant L.
Rev Iberoam Micol · journal article; english abstractEberconazole. WAS 2160.
Författaruppgift saknas
Drugs R D · journal article · DOI 10.2165/00126839-199901020-00012Topical treatment of tinea corporis and tinea cruris with eberconazole (WAS 2160) cream 1% and 2%: a phase II dose-finding pilot study.
del Palacio A, Cuétara S, Rodríguez Noriega A.
Mycoses · clinical trial, phase ii; comparative study; clinical trial; randomized controlled trial; journal article · DOI 10.1111/j.1439-0507.1995.tb00415.xInhibition of two imidazole antimycotics, eberconazole and clotrimazole, by different components of Candida albicans serotype B membrane protoplasts.
Tomás JM, Camprubí S, Merino S, Parés R, Llauradó X, Julve J.
Int J Antimicrob Agents · journal article · DOI 10.1016/0924-8579(93)90006-q